© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Insulin signalling in heart involves insulin receptor substrates-1 and -2, activation of phosphatidylinositol 3-kinase and the JAK 2-growth related pathway
aDepartment of Internal Medicine, University of Campinas—UNICAMP, 13081-970 Campinas SP, Brazil
bDepartment of Medicine I, H.S. Raffaele, Milan, Italy
* Corresponding author. Tel.: +55 (19) 239 7734; Fax: +55 (19) 239 3114.
Objective: Hyperinsulinemia is a common feature of obesity and hypertension and may be associated with abnormal metabolism and growth of heart muscle and vascular wall. Most of the known actions of insulin were characterised in muscle, adipose tissue and liver. In this study we investigate the initial steps of insulin signalling in rat heart. Methods: After insulin infusion in the cava vein of male Wistar rats, the insulin receptor, insulin receptor substrates-1 and -2, phosphatidylinositol 3-kinase activity and Janus kinase (JAK) 2 engagement were studied by immunoprecipitation and immunoblot of heart extracts. Results: An insulin load induces rapid autophosphorylation of the insulin receptor which is followed by the phosphorylation of insulin receptor substrates-1 and -2. The phosphorylation of these early intracellular substrates leads to the association of the p85 subunit of phosphatidylinositol 3-kinase and subsequent activation of its catalytic p110 subunit. Besides activation of the lipid metabolising enzyme phosphatidylinositol 3-kinase, the phosphorylation of insulin receptor substrates-1 and -2 engages the intracellular kinase JAK 2 and induces JAK 2–STAT 1 complex formation. Conclusion: We demonstrate that the early steps of insulin signalling in heart include the phosphorylation–activation of the insulin receptor, engagement of insulin receptor substrates-1 and -2 with the consequent activation of phosphatidylinositol 3-kinase and the involvement of the recently discovered growth related pathway—JAK 2–STAT 1.
KEYWORDS Insulin receptor; Insulin receptor substrate-1 and -2; Phosphatidylinositol 3-kinase; JAK 2; Heart hypertrophy; Rat
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Kurdi and G. W. Booz JAK redux: a second look at the regulation and role of JAKs in the heart Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1545 - H1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Bodell, E. Kodesh, F. Haddad, F. P. Zaldivar, D. M. Cooper, and G. R. Adams Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise J Appl Physiol, February 1, 2009; 106(2): 443 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Giani, M. S. Bonkowski, M. C. Munoz, M. M. Masternak, D. Turyn, A. Bartke, and F. P. Dominici Insulin Signaling Cascade in the Hearts of Long-Lived Growth Hormone Receptor Knockout Mice: Effects of Calorie Restriction J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2008; 63(8): 788 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thawornkaiwong, J. Pantharanontaga, and J. Wattanapermpool Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R844 - R851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Purdom and Q. M. Chen Epidermal Growth Factor Receptor-Dependent and -Independent Pathways in Hydrogen Peroxide-Induced Mitogen-Activated Protein Kinase Activation in Cardiomyocytes and Heart Fibroblasts J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1179 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. Calegari, M. Alves, P. K. Picardi, R. Y. Inoue, K. G. Franchini, M. J. A. Saad, and L. A. Velloso Suppressor of Cytokine Signaling-3 Provides a Novel Interface in the Cross-Talk between Angiotensin II and Insulin Signaling Systems Endocrinology, February 1, 2005; 146(2): 579 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Augustus, H. Yagyu, G. Haemmerle, A. Bensadoun, R. K. Vikramadithyan, S.-Y. Park, J. K. Kim, R. Zechner, and I. J. Goldberg Cardiac-specific Knock-out of Lipoprotein Lipase Alters Plasma Lipoprotein Triglyceride Metabolism and Cardiac Gene Expression J. Biol. Chem., June 11, 2004; 279(24): 25050 - 25057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, S.-O. Kim, N. Yang, J. Jiang, and S. J. Frank Physical and Functional Interaction of Growth Hormone and Insulin-Like Growth Factor-I Signaling Elements Mol. Endocrinol., June 1, 2004; 18(6): 1471 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Desrois, R. J Sidell, D. Gauguier, L. M King, G. K Radda, and K. Clarke Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart Cardiovasc Res, February 1, 2004; 61(2): 288 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. C. Carvalheira, V. C. Calegari, H. G. Zecchin, W. Nadruz Jr., R. B. Guimaraes, E. B. Ribeiro, K. G. Franchini, L. A. Velloso, and M. J. A. Saad The Cross-Talk between Angiotensin and Insulin Differentially Affects Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase-Mediated Signaling in Rat Heart: Implications for Insulin Resistance Endocrinology, December 1, 2003; 144(12): 5604 - 5614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Laviola, G. Belsanti, A. M. Davalli, R. Napoli, S. Perrini, G. C. Weir, R. Giorgino, and F. Giorgino Effects of Streptozocin Diabetes and Diabetes Treatment by Islet Transplantation on In Vivo Insulin Signaling in Rat Heart Diabetes, December 1, 2001; 50(12): 2709 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhong, S. Ahmed, I. L. Grupp, and M. A. Matlib Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1137 - H1147. [Abstract] [Full Text] [PDF]
|
|